Sep 07, 2023 / 03:00PM GMT
Timothy Ian Daley - Wells Fargo Securities, LLC, Research Division - Associate Analyst
Great. So perfect. Thank you, guys, for all attending here. My name is Tim Daley. I am the life science tools analyst here at Wells Fargo. We are very happy to have Bio-Rad here with us for a fireside chat. I am joined here by Norman Schwartz, the President and CEO; and Ilan Daskal, CFO. So with that, we'll kick it off. If we have a few minutes at the end, I might open up to the audience. They got a lot of stuff here. So if nobody's got anything, we'll just keep running through.
Questions and Answers:
Timothy Ian Daley - Wells Fargo Securities, LLC, Research Division - Associate AnalystBut so -- just, I guess, to kick things off, lots of month-to-month volatility across both geographies as well as end markets. So it would be great if you guys could just give us an update on how August demand trends came in? Do things sequentially on a month-to-month basis improve, get worse? Anything stand out in particular.
Norman D. Schwartz - Bio-Rad